A detailed history of Tower Research Capital LLC (Trc) transactions in Scynexis Inc stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 3,323 shares of SCYX stock, worth $3,356. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,323
Previous 5,769 42.4%
Holding current value
$3,356
Previous $11,000 63.64%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$1.27 - $2.23 $3,106 - $5,454
-2,446 Reduced 42.4%
3,323 $4,000
Q2 2024

Aug 13, 2024

SELL
$1.4 - $2.77 $15,075 - $29,827
-10,768 Reduced 65.11%
5,769 $11,000
Q1 2024

May 15, 2024

BUY
$1.39 - $2.21 $15,919 - $25,311
11,453 Added 225.28%
16,537 $24,000
Q4 2023

Feb 13, 2024

BUY
$1.56 - $2.24 $7,927 - $11,383
5,082 Added 254100.0%
5,084 $11,000
Q3 2023

Nov 14, 2023

BUY
$1.93 - $3.64 $3 - $7
2 New
2 $0
Q1 2023

May 09, 2023

BUY
$1.15 - $3.0 $9,986 - $26,052
8,684 Added 212.06%
12,779 $38,000
Q4 2022

Feb 10, 2023

SELL
$1.46 - $2.94 $2,299 - $4,630
-1,575 Reduced 27.78%
4,095 $7,000
Q3 2022

Nov 10, 2022

SELL
$1.83 - $2.93 $22,726 - $36,387
-12,419 Reduced 68.65%
5,670 $13,000
Q2 2022

Aug 15, 2022

BUY
$1.77 - $3.87 $30,821 - $67,388
17,413 Added 2575.89%
18,089 $33,000
Q1 2022

May 12, 2022

SELL
$3.56 - $6.66 $5,076 - $9,497
-1,426 Reduced 67.84%
676 $3,000
Q4 2021

Feb 14, 2022

BUY
$4.94 - $7.69 $10,383 - $16,164
2,102 New
2,102 $13,000
Q3 2021

Nov 15, 2021

SELL
$5.3 - $7.89 $138,457 - $206,118
-26,124 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$6.5 - $9.97 $162,656 - $249,489
25,024 Added 2274.91%
26,124 $192,000
Q1 2021

May 17, 2021

BUY
$6.93 - $9.63 $7,623 - $10,593
1,100 New
1,100 $9,000
Q4 2020

Feb 16, 2021

SELL
$4.28 - $7.87 $5,619 - $10,333
-1,313 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$4.37 - $7.48 $5,737 - $9,821
1,313 New
1,313 $6,000

Others Institutions Holding SCYX

About SCYNEXIS INC


  • Ticker SCYX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 32,651,800
  • Market Cap $33M
  • Description
  • SCYNEXIS, Inc., a biotechnology company, develops products for the treatment fungal infections in the United States. It offers BREXAFEMME (ibrexafungerp tablets) for the treatment of vulvovaginal candidiasis (VVC). The company is developing its lead product candidate, Ibrexafungerp, as a novel oral and intravenous drug for the treatment of vario...
More about SCYX
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.